Texte intégral
Decentralized Procedure DK/H/2754/001/DC
UUID: 4dfb4ba4-f07d-4e39-8615-5201078dfe31 Vizilatan 0,05 mg/ml; eye drops, solution
(active ingredient: Latanoprost) Applicant:
April 2017 Sequence Date of
submission DK BG CZ EL FR HR HU NL PL SK Submission
description Submission
Type Related
Sequence Submission Unit
0000 April 2017 X X X X X X X X X X New application for Marketing
Authorization maa 0000 initial
Documents relatifs
Five clinical studies were conducted for DuoTrav 40 micrograms/mL + 5 mg/mL eye drops, solution (Alcon Laboratories) to support the efficacy and safety of the
[r]
Excipients: Macrogolglycerol hydroxystearate 40, sodium chloride, disodium edetate, sodium dihydrogen phosphate dihydrate, anhydrous disodium phosphate, hydrochloric acid or/and
0,05 mg/ml; eye drops, solution; DKJH/2754/001/DC , in Hungary does not infringe any data exclusivity rights of third parties in the territory
[LATANOPROST] 50 mcg/ml preservative free eye drops, solution is indicated for thereduction of elevated intraocular pressure in patients with open angle glaucoma and
SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN.. Keep out of the sight and reach
The overall efficacy of the bimatoprost 0.03 %/timolol 0.5 % eye drops combination in the treatment of patients with open-angle glaucoma or ocular hypertension
[r]
